While conventional tumor markers such as carcinoembryonic antigen (CEA), cancer antigen (CA)19-9, CA72-4, and alpha-fetoprotein (AFP) are widely used in clinical practice, their utility is limited by moderate sensitivity and specificity. The gene discussed is AFP; the disease is neoplasm.